Search results
Selling Buzz: Abbvie Inc [ABBV] EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas sells 21,082 shares...
Knox Daily· 2 days agoAnalyzing ABBV Stock Performance During the last five days, there has been a drop of approximately -2.55%. Over the course of the year, Abbvie Inc shares ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 16 hours agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Monitoring Abbvie Inc (ABBV) after recent insider movements – Knox Daily
Knox Daily· 5 days agoAbbvie Inc’s filing revealed that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million ...
AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands of...
JD Supra· 2 days agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 7 hours agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Add These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield...
Benzinga via Yahoo Finance· 3 days agoHigh-quality, low-risk dividend stocks offer a solid income stream while cushioning your portfolio...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 18 hours agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald’s price objective would suggest a potential upside of 20.18% from the stock’s previous close. Barclays decreased their target price on AbbVie from $195.00 to $187.00 and set ...
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks...
Benzinga· 7 days agoPresident Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 4 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
